143 related articles for article (PubMed ID: 34478783)
1. Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis.
Neale H; Michelon M; Jacob S; Pinkston M; Ukaegbu R; Zamor W; Morrison E; Deng A; Levin NA
J Am Acad Dermatol; 2022 Aug; 87(2):423-425. PubMed ID: 34478783
[No Abstract] [Full Text] [Related]
2. Topical chemotherapy of basal and squamous skin cancers with 5-fluorouracil cream.
Litwin MS; Krementz ET
Panminerva Med; 1974 Mar; 16(3):84-5. PubMed ID: 4449647
[No Abstract] [Full Text] [Related]
3. Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
Hsu SH; Gan SD; Nguyen BT; Konnikov N; Liang CA
Dermatol Surg; 2016 Sep; 42(9):1050-3. PubMed ID: 27359199
[TBL] [Abstract][Full Text] [Related]
4. Proceedings: Use of 5 fluorouracil in the topical therapy of skin cancer: a review of 157 patients.
Litwin MS; Ryan RF; Ichinose H; Reed RR; Kremetz ET
Proc Natl Cancer Conf; 1972; 7():549-61. PubMed ID: 4764922
[No Abstract] [Full Text] [Related]
5. A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
Sillman FH; Sedlis A; Boyce JG
Obstet Gynecol Surv; 1985 Apr; 40(4):190-220. PubMed ID: 2984615
[No Abstract] [Full Text] [Related]
6. The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers.
Ramsay JR; Suhrbier A; Aylward JH; Ogbourne S; Cozzi SJ; Poulsen MG; Baumann KC; Welburn P; Redlich GL; Parsons PG
Br J Dermatol; 2011 Mar; 164(3):633-6. PubMed ID: 21375515
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
8. Delayed hypersensitivity to 5-fluorouracil following topical chemotherapy of cutaneous cancers.
Mansell PW; Litwin MS; Ichinose H; Krementz ET
Cancer Res; 1975 May; 35(5):1288-94. PubMed ID: 1120313
[TBL] [Abstract][Full Text] [Related]
9. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
Queen D; Trager MH; Fan W; Gordon ER; Samie FH
Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
Beatson M; Means AD; Leader NF; Robinson-Bostom L; Weinstock MA
Acta Derm Venereol; 2019 Jun; 99(7):707-708. PubMed ID: 30896781
[No Abstract] [Full Text] [Related]
11. [Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Zala L
Dermatologica; 1972; 145(5):326-33. PubMed ID: 4654411
[No Abstract] [Full Text] [Related]
12. Clinical and structural evaluation of the treatment of some hyperplastic and neoplastic skin diseases with 5-fluorouracil (5-FU) ointment.
Binazzi M
Dermatologica; 1970; 140():Suppl 1:90-6. PubMed ID: 5471369
[No Abstract] [Full Text] [Related]
13. Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma.
Mohs FE; Jones DL; Bloom RF
Arch Dermatol; 1978 Jul; 114(7):1021-2. PubMed ID: 686718
[TBL] [Abstract][Full Text] [Related]
14. Metallic taste as a side effect of topical fluorouracil use.
Han SY; Youker S
J Drugs Dermatol; 2011 Oct; 10(10):1201-3. PubMed ID: 21968673
[TBL] [Abstract][Full Text] [Related]
15. Erythroplasia of Queyrat.
Goette DK
Arch Dermatol; 1974 Aug; 110(2):271-3. PubMed ID: 4851903
[No Abstract] [Full Text] [Related]
16. The topical application of 5-fluorouracil in the treatment of skin lesions.
Kastl WH; Knoepp LF; Soosaar A
J La State Med Soc; 1969 Jul; 121(7):216-8. PubMed ID: 5797536
[No Abstract] [Full Text] [Related]
17. 5-fluorouracil (5-FU) ointment in the treatment of basal cell epithelioma. Histological control over a long duration.
Achten G; Van Oost A; Ledoux-Corbusier M
Dermatologica; 1970; 140():Suppl 1:59-64. PubMed ID: 5471364
[No Abstract] [Full Text] [Related]
18. Nodular superficial pigmented basal cell epitheliomas.
Shelley WB; Wood MG
Arch Dermatol; 1982 Nov; 118(11):928-30. PubMed ID: 7138053
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
20. [Topical use of antineoplastic agents in precancerous conditions of the skin].
Gartmann H
Z Hautkr; 1977 Apr; 52(8):463-5. PubMed ID: 868199
[No Abstract] [Full Text] [Related]
[Next] [New Search]
